Enfuvirtide (T20; DP178) is an anti-HIV-1 fusion inhibitor peptide and the first agent of its class active against HIV. It has not been linked to serum aminotransferase elevations or clinically apparent liver injury during therapy. Reagent-grade; for laboratory research purposes only.
Usually ships within 24 hours.